6.5
Hold
Average of 2 AIs
↓ Declined from previous
Last Updated: 6 Mar 2026, 07:15 am IST | Report Date: Feb 14, 2026

Sree Rayalaseema Hi-Strength Hypo Limited Stock Analysis

SRHHYPOLTD NSE 🇮🇳 India
6.0
ChatGPT
Hold
7.0
Claude
Buy

Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) is a India-based company listed on NSE. This AI-powered analysis provides investment insights based on quarterly earnings reports and financial performance metrics.

Share Share Share

Sree Rayalaseema Hi-Strength Hypo demonstrates solid fundamental strength with Q3 FY2025-26 revenue growth of 1.95% YoY to Rs. 14,117.40 lakhs and nine-month revenue expansion to Rs. 50,381.93 lakhs from Rs. 47,734.36 lakhs. The company maintains healthy profitability with EBITDA margin of 28.84%, operating margin of 27.96%, and net profit margin of 17.25%, while the exceptionally strong interest coverage ratio of 95.43x indicates minimal financial leverage risk. Export diversification contributing 37.5% of nine-month revenue (Rs. 18,891.35 lakhs) reduces geographic concentration, though the one-time exceptional charge of Rs. 322.26 lakhs from Labour Code compliance and significant other comprehensive loss of Rs. 1,491.13 lakhs from FVTOCI instruments warrant monitoring. The stable EPS of Rs. 14.18 and strong other income performance of Rs. 1,945.42 lakhs suggest resilient earnings quality despite operational headwinds.

Based on: Sree Rayalaseema Hi-Strength Hypo Limited - Financial Results (14/2/2026) (Feb 14, 2026)

AI Investment Score & Analysis

+ Key Strengths

Robust EBITDA margin of 28.84% in Q3 FY2025-26 with operating margin of 27.96% and net profit margin of 17.25% demonstrates strong pricing power and operational efficiency in the chemicals segment
Exceptionally low financial leverage with interest coverage ratio of 95.43x indicating negligible debt burden and financial flexibility for future growth investments
Balanced revenue mix with exports contributing 37.5% (Rs. 18,891.35 lakhs) and domestic sales 62.5% (Rs. 31,490.58 lakhs) during nine months, reducing dependency on single geographic market
Healthy nine-month revenue growth from Rs. 47,734.36 lakhs to Rs. 50,381.93 lakhs showing sustained business momentum across both domestic and international markets
Strong other income generation of Rs. 1,945.42 lakhs in Q3 versus Rs. 1,256.22 lakhs in Q3 FY2024-25 provides earnings cushion and indicates effective treasury management
No customer concentration risk with no single customer representing 10% or more of total revenue, ensuring diversified revenue streams and reduced counterparty risk

- Key Risks

Material costs at 52.2% of revenue in Q3 (Rs. 7,371.02 lakhs absolute) expose the company to raw material price volatility in the chemicals segment with limited pricing flexibility visible in modest 1.95% revenue growth
Significant other comprehensive loss of Rs. 1,491.13 lakhs in Q3 primarily from FVTOCI financial instruments indicates volatile mark-to-market exposures that reduced total comprehensive income to Rs. 940.30 lakhs despite strong operating performance
Labour Code implementation in November 2025 resulted in exceptional charge of Rs. 322.26 lakhs for gratuity liability adjustments, with potential for ongoing compliance costs and operational adjustments in subsequent quarters
Revenue concentration in single chemicals segment creates sector-specific cyclical exposure with wind energy contributing less than 10%, limiting diversification benefits during industry downturns
Absence of complete balance sheet data prevents assessment of working capital efficiency, asset turnover, liquidity ratios, and debt positioning beyond equity of Rs. 92,232.73 lakhs
Missing cash flow statement data prevents evaluation of operating cash generation, free cash flow conversion, capex sustainability, and actual cash earnings quality behind reported profits

Forward Outlook

The report provides minimal forward-looking guidance, with no announcements of new capacity expansions, product launches, strategic partnerships, or major capex commitments during Q3 FY2025-26. The company remains focused on its core chemicals business with existing operational facilities concentrated in India, and management has not disclosed pipeline projects or specific growth initiatives for upcoming quarters. Based on observed momentum, revenue growth appears stable but decelerating at 1.95% YoY in Q3, suggesting the business is in a consolidation phase rather than expansion mode. The 37.5% export contribution provides a platform for geographic diversification, though no specific international market penetration strategies were articulated. Investors should monitor upcoming quarters for signs of margin sustainability given high material costs at 52.2% of revenue, management's response to Labour Code compliance costs, and any strategic initiatives to accelerate the modest topline growth trajectory.

Detailed AI Analysis by Provider

6.0
OpenAI ChatGPT Hold
codex-cli (OpenAI Codex)

Overall verdict: SRHHYPOLTD shows resilient profitability but only modest growth, supporting a Hold stance over a 6-12 month horizon. Q3 FY2025-26 revenue from operations rose just 1.95% YoY to Rs. 14,117.40 lakhs, but EBITDA margin remained strong at 28.84% and operating margin at 27.96%, indicating good operating discipline. Profit before tax increased to Rs. 3,481.88 lakhs, while reported PAT of Rs. 2,434.69 lakhs was reduced by a Rs. 322.85 lakhs exceptional labour-code related charge; adjusted PAT was higher at Rs. 2,757.54 lakhs. Earnings quality is mixed because other income was sizable at Rs. 1,945.42 lakhs versus revenue growth of only 1.95%, and OCI posted a Rs. 1,491.13 lakhs loss that dragged total comprehensive income to Rs. 940.30 lakhs.

Forward Outlook

Strategically, the company remained focused on its core chemicals segment in Q3, with wind energy still contributing less than 10% and no major new project, acquisition, or capacity expansion disclosed. The key reported strategic development was compliance with the November 2025 Labour Code changes, reflected in the one-time gratuity-related exceptional charge. For the next 2-4 quarters, momentum appears stable rather than accelerating: nine-month revenue is up, but quarterly YoY growth is modest at 1.95% while margins remain strong. Near-term performance is likely to depend on sustaining chemicals demand, preserving the current margin profile, and reducing earnings volatility from non-operating and OCI movements.

Strengths

EBITDA stayed robust at Rs. 4,072.01 lakhs with a 28.84% margin in Q3, showing strong core profitability despite modest top-line growth.
Operating margin (27.96%) and net profit margin (17.25%) indicate healthy earnings capacity for the quarter.
Interest coverage of 95.43x and low finance costs of Rs. 41.37 lakhs versus EBIT of Rs. 3,946.19 lakhs suggest very strong debt-servicing comfort.
Nine-month revenue from operations rose to Rs. 50,381.93 lakhs from Rs. 47,734.36 lakhs, supporting continued, if moderate, growth momentum.
Revenue mix is geographically diversified with India at 62.5% and exports at 37.5%, and no single customer contributes 10%+ of revenue.

Risks

Q3 revenue growth was only 1.95% YoY (Rs. 14,117.40 lakhs), signaling slower growth momentum versus strong profitability levels.
Reported earnings were affected by a Rs. 322.85 lakhs exceptional labour-code related charge, highlighting regulatory-cost sensitivity.
Other comprehensive income recorded a large loss of Rs. 1,491.13 lakhs (FVTOCI-related), introducing volatility in total comprehensive returns.
Other income of Rs. 1,945.42 lakhs is large relative to operating revenue, which can weaken earnings quality if not consistently recurring.
Cash flow, capex, liquidity and working-capital metrics are largely unavailable in the provided data, limiting visibility on cash conversion and funding resilience.
7.0
Anthropic Claude Buy
claude-cli (Claude Code)

Sree Rayalaseema Hi-Strength Hypo demonstrates solid fundamental strength with Q3 FY2025-26 revenue growth of 1.95% YoY to Rs. 14,117.40 lakhs and nine-month revenue expansion to Rs. 50,381.93 lakhs from Rs. 47,734.36 lakhs. The company maintains healthy profitability with EBITDA margin of 28.84%, operating margin of 27.96%, and net profit margin of 17.25%, while the exceptionally strong interest coverage ratio of 95.43x indicates minimal financial leverage risk. Export diversification contributing 37.5% of nine-month revenue (Rs. 18,891.35 lakhs) reduces geographic concentration, though the one-time exceptional charge of Rs. 322.26 lakhs from Labour Code compliance and significant other comprehensive loss of Rs. 1,491.13 lakhs from FVTOCI instruments warrant monitoring. The stable EPS of Rs. 14.18 and strong other income performance of Rs. 1,945.42 lakhs suggest resilient earnings quality despite operational headwinds.

Forward Outlook

The report provides minimal forward-looking guidance, with no announcements of new capacity expansions, product launches, strategic partnerships, or major capex commitments during Q3 FY2025-26. The company remains focused on its core chemicals business with existing operational facilities concentrated in India, and management has not disclosed pipeline projects or specific growth initiatives for upcoming quarters. Based on observed momentum, revenue growth appears stable but decelerating at 1.95% YoY in Q3, suggesting the business is in a consolidation phase rather than expansion mode. The 37.5% export contribution provides a platform for geographic diversification, though no specific international market penetration strategies were articulated. Investors should monitor upcoming quarters for signs of margin sustainability given high material costs at 52.2% of revenue, management's response to Labour Code compliance costs, and any strategic initiatives to accelerate the modest topline growth trajectory.

Strengths

Robust EBITDA margin of 28.84% in Q3 FY2025-26 with operating margin of 27.96% and net profit margin of 17.25% demonstrates strong pricing power and operational efficiency in the chemicals segment
Exceptionally low financial leverage with interest coverage ratio of 95.43x indicating negligible debt burden and financial flexibility for future growth investments
Balanced revenue mix with exports contributing 37.5% (Rs. 18,891.35 lakhs) and domestic sales 62.5% (Rs. 31,490.58 lakhs) during nine months, reducing dependency on single geographic market
Healthy nine-month revenue growth from Rs. 47,734.36 lakhs to Rs. 50,381.93 lakhs showing sustained business momentum across both domestic and international markets
Strong other income generation of Rs. 1,945.42 lakhs in Q3 versus Rs. 1,256.22 lakhs in Q3 FY2024-25 provides earnings cushion and indicates effective treasury management
No customer concentration risk with no single customer representing 10% or more of total revenue, ensuring diversified revenue streams and reduced counterparty risk

Risks

Material costs at 52.2% of revenue in Q3 (Rs. 7,371.02 lakhs absolute) expose the company to raw material price volatility in the chemicals segment with limited pricing flexibility visible in modest 1.95% revenue growth
Significant other comprehensive loss of Rs. 1,491.13 lakhs in Q3 primarily from FVTOCI financial instruments indicates volatile mark-to-market exposures that reduced total comprehensive income to Rs. 940.30 lakhs despite strong operating performance
Labour Code implementation in November 2025 resulted in exceptional charge of Rs. 322.26 lakhs for gratuity liability adjustments, with potential for ongoing compliance costs and operational adjustments in subsequent quarters
Revenue concentration in single chemicals segment creates sector-specific cyclical exposure with wind energy contributing less than 10%, limiting diversification benefits during industry downturns
Absence of complete balance sheet data prevents assessment of working capital efficiency, asset turnover, liquidity ratios, and debt positioning beyond equity of Rs. 92,232.73 lakhs
Missing cash flow statement data prevents evaluation of operating cash generation, free cash flow conversion, capex sustainability, and actual cash earnings quality behind reported profits

Score History

Score Timeline

Quarterly Report News Event

All Scores

Date Report Score Sentiment AI
Mar 6, 2026 Sree Rayalaseema Hi-Strength Hypo Limited - Financial Results (14/2/2026) 6.0 Hold ChatGPT
Feb 28, 2026 Sree Rayalaseema Hi-Strength Hypo Limited - Financial Results (14/2/2026) 7.0 Buy Claude

Related Stocks on NSE

Reliance Communications Limited
RCOM
1.5
PTC India Financial Services Limited
PFS
5.0
Uravi Defence and Technology Limited
URAVIDEF
5.8
Rajesh Exports Limited
RAJESHEXPO
5.4
Algoquant Fintech Limited
ALGOQUANT
6.0
Religare Enterprises Limited
RELIGARE
4.0
HDFC Bank Limited
HDFCBANK
7.5
Construction
ORIENTALTL
5.0

Frequently Asked Questions

What is the AI Stock Score?

The AI Stock Score is a composite rating from 0-10 generated by analyzing quarterly earnings reports using three leading AI models (Google Gemini, Anthropic Claude, and OpenAI ChatGPT). Each AI independently evaluates financial performance, growth prospects, risks, and market positioning to provide an objective investment perspective.

How should I interpret Buy/Hold/Sell ratings?

Buy (7.0-10.0): Strong fundamentals and positive outlook. Hold (4.0-6.9): Mixed signals, suitable for existing positions. Sell (0-3.9): Deteriorating fundamentals or significant risks. These are AI-generated opinions for informational purposes only, not investment advice.

How is the composite score calculated?

The composite score is the mathematical average of the latest scores from each AI provider. For example, if Gemini rates 7.5, Claude rates 4.5, and ChatGPT rates 6.0, the composite score would be (7.5+4.5+6.0)/3 = 6.0. This multi-AI approach reduces bias from any single model.

How often are scores updated?

Scores are automatically generated within hours of quarterly earnings results being published on NSE. The system monitors earnings announcements 4 times daily and processes new reports immediately. Check the "Last Updated" date at the top of this page for the most recent analysis timestamp.

Is this financial advice?

No. This is AI-generated analysis for informational and educational purposes only. MarketsHost is not a SEBI-registered Research Analyst or Investment Adviser. AI models can produce inaccurate results. Always consult a qualified financial advisor and conduct your own due diligence before making investment decisions.